Quick Answer
Tiziana Life Sciences Ltd reported Research And Development Expense of $5.23 million for the year ending 2024.
- Tiziana Life Sciences Ltd showed a decrease of -35.5% in Research And Development Expense from 2023 to 2024.
- This data is from Tiziana Life Sciences Ltd's annual report (Form 10-K), filed with the SEC on May 6, 2025.
- XBRL data for this metric is available from 2016 to 2024 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 9 years of available data (2016 to 2024), Tiziana Life Sciences Ltd's Research And Development Expense has grown by 30.5%.
- Historical annual values: Fiscal year 2024: $5.23 million | Fiscal year 2023: $8.11 million | Fiscal year 2022: $12.96 million | Fiscal year 2021: $13.21 million | Fiscal year 2020: $5.99 million | Fiscal year 2019: $3.71 million | Fiscal year 2018: $5.51 million | Fiscal year 2017: $6.02 million | Fiscal year 2016: $4.01 million.
- Data sourced from SEC EDGAR public filings as of June 21, 2026.
Last verified: